LC-SF-14
LC-SF-14 is a selective dual inhibitor of SHP2 and FGFR (IC50 values are 71.6 and 8.9 nM, respectively) . LC-SF-14 inhibits FGFR2-FRS2α-SHP2-MAPK signaling and ERK phosphorylation. LC-SF-14 inhibits the proliferation of KATOIII cancer cells (IC50: 9.2 nM) . LC-SF-14 has antitumor activity in the SNU-16 xenograft mouse model. LC-SF-14 can be used in FGFR2-driven gastric cancer research[1].
Product Specifications
UNSPSC
12352211
Target
ERK; FGFR; p38 MAPK; SHP2
Related Pathways
MAPK/ERK Pathway; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Field of Research
Cancer
Smiles
O=C(NC1=CC=CC(SC2=NC=C(N3CCC(C)(N)CC3)N=C2N)=C1Cl)CCC(N4CCN(C5=CC=C(NC6=NC=NC(N(C)C(NC7=C(Cl)C(OC)=CC(OC)=C7Cl)=O)=C6)C=C5)CC4)=O
Molecular Formula
C44H50Cl3N13O5S
Molecular Weight
979.38
References & Citations
[1]Zheng L, et al. Discovery of LC-SF-14, a selective dual inhibitor of SHP2 and FGFR for the treatment of FGFR2-driven gastric cancer. Eur J Med Chem. 2025 May 11;294:117745.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2606705 3x 1.0 µg
VAX2 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details ![Rabbit Polyclonal TRPC3 Antibody [Alexa Fluor 647]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
NBP2-32258AF647 0.1 mL
Rabbit Polyclonal TRPC3 Antibody [Alexa Fluor 647]
Sign In for Pricing
View Details NBP2-11166 0.1 mg
Doublecortin Overexpression Lysate (Native) - (Dry Ice)
Sign In for Pricing
View Details NBP2-25245DL594 0.1 mL
Mouse Monoclonal TLR2 Antibody (67N8F8) [DyLight 594]
Sign In for Pricing
View Details